Burdick Kenneth A's Form 4 filing
LifeStance Health Group, Inc.LFST · filed Aug 12, 2025
- Accession no.
- 0000950170-25-107382
- Filed
- Aug 12, 2025
- Trade date
- Aug 8-11, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions. Open-market purchases total $498.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Burdick Kenneth ACIK 0001498992 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 8, 2025 | Common Stock | PPurchaseAcquired | +45,870 | $4.36 | +$199,993.2 | 3,414,771 | Direct | |
| Aug 8, 2025 | Common Stock | PPurchaseAcquired | +1,800 | $4.31 | +$7,758 | 3,416,571 | Direct | |
| Aug 11, 2025 | Common Stock | PPurchaseAcquired | +1,340 | $4.35 | +$5,829 | 3,417,991 | Direct | |
| Aug 11, 2025 | Common Stock | PPurchaseAcquired | +18,660 | $4.54 | +$84,716.4 | 3,436,571 | Direct | |
| Aug 8, 2025 | Common Stock | PPurchaseAcquired | +46,511 | $4.30 | +$199,997.3 | 46,511 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.